Section Review: Oncologic, Endocrine & Metabolic: Topoisomerase I inhibitors in gynaecologic cancers
- 1 December 1995
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 4 (12) , 1217-1232
- https://doi.org/10.1517/13543784.4.12.1217
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Marked Interspecies Variations Concerning the Interactions of Camptothecin with Serum Albumins: A Frequency-Domain Fluorescence Spectroscopic StudyBiochemistry, 1994
- Therapeutic efficacy of camptothecin derivatives against human malignant melanoma xenograftsMelanoma Research, 1994
- Preferential Binding of the Carboxylate Form of Camptothecin by Human Serum AlbuminAnalytical Biochemistry, 1993
- The Pyrazoloacridines: Approaches to the Development of a Carcinoma-Selective Cytotoxic AgentCancer Investigation, 1990
- The problem of the quiescent cancer cellAdvances in Enzyme Regulation, 1989
- A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal ringsCell, 1989
- DNA topoisomerases and DNA repairBioEssays, 1988
- Action at a Distance Along a DNAScience, 1988
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- Degree of superhelicity of covalently closed cyclic DNA's from Escherichia coliJournal of Molecular Biology, 1969